期刊文献+

Tenuigenin对转染APP695cDNA的SH-SY5Y细胞β-淀粉样蛋白生成的抑制作用及机制 被引量:1

Inhibitory Effect of Tenuigenin on Beta Amyloid Protein Production of SH-SY5Y Cells Transfected with APP695 cDNA
下载PDF
导出
摘要 目的用转染APP695cDNA的SH-SY5Y细胞模型,研究tenuigenin对β-淀粉样蛋白(Aβ)生成的抑制作用及其作用机制。方法应用免疫沉淀和蛋白印迹法(Westernblot)检测Aβ含量,应用MTT和LDH法测定tenuigenin的细胞毒性。结果Tenuigenin降低SH-SY5YAPP695细胞Aβ分泌水平;无细胞增生和毒性作用;能抑制SH-SY5YAPP695细胞APPC99的生成,但对SH-SY5YSPA4CT细胞APPC99生成无抑制作用,亦不影响该细胞株Aβ的分泌。结论Tenuigenin可能通过抑制β-分泌酶对APP的水解,降低SH-SY5YAPP695细胞Aβ水平。Tenuigenin这一针对阿尔茨海默病(Alzheimerdisease,AD)上游病理环节的药效,显示了其在AD治疗方面重要的开发和临床应用的价值,值得进一步研究。 Objective To investigate the inhibitory effect of tenuigenin on beta amyloid protein(Aβ) which caused Alzheimer's Disease(AD). Methods Western blotting was used to test the Aβ and C99 levels of cells; MTT and LDH was used to test the neurotoxicity of tenuigenin to the cells. Results Tenuigenin can inhibit the production of beta amyloid protein of SH-SY5Y APP695 cells, didn't have neurotoxicity to cells; it can decrease Aβ and C99 levels of SH-SY5Y APP695 cells, but it didn't decrease Aβ and C99 levels of SH-SYSY SPA4CT cells. Conclusion Tenuigenin can inhibit the production of beta amylold protein of SH-SYSY APP695 cells, it's mechanism may come through affecting the β-secretase proteolytic activities.
出处 《首都医科大学学报》 CAS 2005年第4期428-431,共4页 Journal of Capital Medical University
基金 国家自然科学科学基金(39870276 39840010) 国家重大基础项目研究基金(G1999064007) 北京市中医药管理局科研基金(JJ99-26)资助项目
关键词 阿尔茨海默病 Β-淀粉样蛋白 C99 免疫沉淀Western印迹法 Alzheimer disease(AD) amyloid β-peptides(Aβ) C99 Western blotting
  • 相关文献

参考文献1

二级参考文献16

  • 1Wu P, Du Qy, Hu RZ, et al. The chemical, pharmacological and clinical research for Polygala tenuifolia Willd. [J]. J Strait Pharm (海峡药学), 1999,11(2):108-109. 被引量:1
  • 2Li WK, Liang XY. The component and pharmacological activity of saponins in the officinal plant of Polygala L. [J]. World Phytomed (国外医药:植物药分册), 1998,13(2):60-62. 被引量:1
  • 3Zhang JT, Saito H. Studies on susceptibilities to the amnestic effects of 12 chemicals on passive avoidance responses in mice: comparison between step down and step through tests [J]. Acta Pharm Sin (药学学报), 1986,21(1):12-16. 被引量:1
  • 4Chen Q. The Experimental Methods for Antiaging Research (抗衰老研究实验方法) [M]. Beijing: China Medico-Pharm Aceutical Science and Technology Publishing House, 1996.108-110. 被引量:1
  • 5Leventer S, Mckeag D, Clancy M, et al. Intracerebroventricular administration of ethyl-choline mustard aziridinium ion (AF64A) reduces release of acetylcholine from rat hippocampal slices [J]. Neuropharmacology, 1985,24(5):453-459. 被引量:1
  • 6Irizarry MC, Hyman BT. Alzheimer disease therapeutics [J]. J Neuropathol Exp Neurol, 2001,60(10):923-928. 被引量:1
  • 7Lemiere J, Van Gool D, Dom R. Treatment of Alzheimer's disease: an evaluation of the cholinergic approach [J]. Acta Neurol Belg, 1999,99(2):96-106. 被引量:1
  • 8Yamada K, Ren X, Nabeshima T. Perspectives of pharmacotherapy in Alzheimer's disease [J]. Jpn J Pharmacol, 1999,80(1):9-14. 被引量:1
  • 9Nitta A, Fukuta T, Hasegawa T, et al. Continuous infusion of beta-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration [J]. Jpn J Pharmacol, 1997,73(1):51-57. 被引量:1
  • 10Pavia J, Alberch J, Alvarez I, et al. Repeated intracerebroventricular administration of beta-amyloid (25~35) to rats decreases muscarinic receptors in cerebral cortex [J]. Neurosci Lett, 2000,278(1-2):69-72. 被引量:1

共引文献54

同被引文献30

  • 1田建英,张晓,官志忠,袁万斌.微量Aβ_(1-40)诱导的α3、α7烟碱型乙酰胆碱能受体的低表达(一种老年性痴呆细胞模型)[J].中风与神经疾病杂志,2004,21(4):344-346. 被引量:5
  • 2杨晓娟,张生林,陈芸,侯玉立.新型复合式老年痴呆动物模型的建立[J].中西医结合心脑血管病杂志,2006,4(4):318-320. 被引量:24
  • 3Xianhao Xu;Hong Guo;Bin Qin.Study of dementia in China[A]New York and London:PLENUM PRESS. 被引量:1
  • 4Goedert M;Spillantini MG.A Century of Alzheimer's disease[J]Science,2006(5800):777-781. 被引量:1
  • 5Doi Y;Mizuno T;Maki Y.Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid (beta) neurotoxicity in in vitro and in vivo models of Alzheimer's disease[J]American Journal of Pathology,2009(07):662-670. 被引量:1
  • 6Tuppo EE;Arias HR.The role of inflammation in Alzheimer's disease[J]International Journal of Biochemistry & Cell Biology,2005(02):289-305. 被引量:1
  • 7Qin B;Cartier L;Dubois-Dauphin M.A Key role for the microglial NADPH oxidase in APP-dependent killing of neurons[J]Neurobiology of Aging,2006(11):1577-1587. 被引量:1
  • 8Ester A;Vicent C;Josefa M.A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer's disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation[J]BrainPathology,2003(04):440-451. 被引量:1
  • 9Backstrom A;Hasslund;Hiller.Regulation of microtubule-associated protein tau and amyloid-precursor protein APP during SH-SY5Y differentiation[J]European Journal of Biochemistry,2003(Suppl 1):169-170. 被引量:1
  • 10Bar-Am O;Weinreb O;Amit T.The novel choliesterase-monoamine oxidase inhibitor and antioxidant,ladostigil,confers neuroprotection in neuroblastoma cells and aged rats[J]Journal of Molecular Neuroscience,2009(02):135-145. 被引量:1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部